Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis

Clinica Chimica Acta

Volumn 384, Issue 1-2, 2007, Pages 99-104

  Nishida, Makoto ^a   Moriyama, Toshiki ^a   Ishii, Kouki ^a   Takashima, Seiji ^a   Yoshizaki, Kazuyuki ^a   Sugita, Yoshiro ^a   Yamauchi Takihara, Keiko ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Gender; Inflammation; Intima media thickness; Metabolic syndrome; Pulse wave velocity

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; HUMAN; INFLAMMATION; INTIMA; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE WAVE; RISK FACTOR; STATISTICAL ANALYSIS; THICKNESS; TUNICA MEDIA;

ADIPONECTIN; ADULT; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TUNICA INTIMA;

EID: 34547890351     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.06.009     Document Type: Article

References (29)

1. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
2. Luc G., Bard J.M., Juhan-Vague I., et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol 23 (2003) 1255-1261
3. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
5. Lorenz M.W., von Kegler S., Steinmetz H., Markus H.S., and Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 37 (2006) 87-92
6. Sutton-Tyrrell K., Najjar S.S., Boudreau R.M., et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 111 (2005) 3384-3390
7. Blackburn R., Giral P., Bruckert E., et al. Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler Thromb Vasc Biol 21 (2001) 1962-1968
8. Yasmin, McEniery C.M., Wallace S., Mackenzie I.S., Cockcroft J.R., and Wilkinson I.B. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 24 (2004) 969-974
9. Mahmud A., and Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 46 (2005) 1118-1122
10. Iglseder B., Cip P., Malaimare L., Ladurner G., and Paulweber B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 36 (2005) 1212-1217
11. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 66 (2002) 987-992
12. Grundy S.M., Cleeman J.I., Donato K.A., et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
13. Nishimoto N., Sasai M., Shima Y., et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95 (2000) 56-61
14. Arita Y., Kihara S., Ouchi N., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
15. Shirai K., Utino J., Otsuka K., and Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb 13 (2006) 101-117
16. Kasayama S., Saito H., Mukai M., and Koga M. Insulin sensitivity independently influences brachial-ankle pulse-wave velocity in non-diabetic subjects. Diabet Med 22 (2005) 1701-1706
17. Ryo M., Nakamura T., Kihara S., et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 68 (2004) 975-981
18. Shaw L.J., Bairey Merz C.N., Pepine C.J., et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 47 3 Suppl (2006) S4-S20
19. Shaw L.J., Lewis J.F., Hlatky M.A., et al. Women's Ischemic Syndrome Evaluation: current status and future research directions, report of the National Heart Lung Blood Institute (NHLBI) workshop, section 5: gender-related risk factors for ischemic heart disease, October 2-4, 2002. Circulation 109 (2004) 56e-58e
20. Marroquin O.C., Kip K.E., Kelley D., et al. The metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 109 (2004) 714-721
21. Bonora E., Kiechl S., Willeit J., et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 26 (2003) 1251-1257
22. Ahluwalia N., Drouet L., Ruidavets J.B., et al. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sample. Atherosclerosis 186 (2006) 345-353
23. Scuteri A., Najjar S.S., Muller D.C., et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 43 (2004) 1388-1395
24. Iannuzzi A., De Michele M., Bond M.G., et al. Carotid artery remodeling in middle-aged women with the metabolic syndrome (from the "Progetto ATENA" study). Am J Cardiol 96 (2005) 1162-1165
25. Wang T.J., Nam B.H., Wilson P.W., et al. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 22 (2002) 1662-1667
26. Makita S., Nakamura M., and Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke 36 (2005) 2138-2142
27. Dandona P., Aljada A., Chaudhuri A., Mohanty P., and Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 (2005) 1448-1454
28. Matsuzawa Y. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3 (2006) 35-42
29. Liu K.H., Chan Y.L., Chan W.B., Chan J.C., and Chu C.W. Mesenteric fat thickness is an independent determinant of metabolic syndrome and identifies subjects with increased carotid intima-media thickness. Diabetes Care 29 (2006) 379-384